Abstract
The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole- resistant isolates.
Cite
CITATION STYLE
APA
Law, D., Moore, C. B., & Denning, D. W. (1997). Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrobial Agents and Chemotherapy, 41(10), 2310–2511. https://doi.org/10.1128/aac.41.10.2310
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free